drugset / Trial / NCT00204269

Three-Year Trial on a New Testosterone Gel

NCT00204269

RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of the study is to examine the efficacy and tolerability of a three-year-Testosterone replacement therapy in hypogonadal patients as well as the patient's compliance. The replacement therapy will be performed with a new Testosterone Gel examined in previous trials as Testosteron Gel Wolff.

Timeline

Start
2003-01
Primary completion
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule Topical

Indications